A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age
Clinical trial NCT05903183 · COMPLETED
Trial details
- NCT number
- NCT05903183
- Sponsor
- Icosavax, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2023-06-05
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.